Aprocitentan has been found to be effective in lowering blood pressure in patients with chronic kidney disease and resistant hypertension. This medication has shown promise in managing the challenging condition of high blood pressure in patients with kidney disease. The use of cookies is also mentioned in the content, indicating that the website uses cookies for analytics, advertising, and to improve the site. By continuing to use the site, users agree to the use of cookies. To learn more, users can refer to the Cookie Policy and Cookie Settings.
Source link
Aprocitentan effective for BP lowering in patients with CKD and resistant hypertension
